Breaking News Instant updates and real-time market news.

ALIOF

Actelion

$184.01

30.46 (19.84%)

, JNJ

Johnson & Johnson

$114.13

1.06 (0.94%)

07:20
11/28/16
11/28
07:20
11/28/16
07:20

Actelion could be acquired for $215 per share, says Wells Fargo

After Johnson & Johnson (JNJ) said that it's in preliminary talks about a deal with Actelion (ALIOF), Wells Fargo estimates that J&J could buy Actelion for $215 per share. The firm thinks that other bidders could emerge for Actelion. It estimates that the deal could be accretive to J&J's EPS by about 5%. Wells keeps an Outperform rating on J&J.

ALIOF

Actelion

$184.01

30.46 (19.84%)

JNJ

Johnson & Johnson

$114.13

1.06 (0.94%)

  • 29

    Nov

ALIOF Actelion
$184.01

30.46 (19.84%)

JNJ Johnson & Johnson
$114.13

1.06 (0.94%)

10/18/16
UBSW
10/18/16
NO CHANGE
Target $137
UBSW
Buy
Johnson & Johnson robust pipeline underappreciated, says UBS
UBS analyst Matt Miksic said the Johnson & Johnson pipeline remains robust and is underappreciated. The analyst said the recent launch of biosimilars removes uncertainty and should be positive for the stock. He also expects the additional deployment of the company's capital - to expand its pipeline through in-licensing, partnerships or mid-sized acquisitions - to be incremental to his Buy thesis. Miksic has a $137 price target on Johnson & Johnson shares.
10/19/16
LEER
10/19/16
NO CHANGE
Target $140
LEER
Outperform
Johnson & Johnson should be bought on weakness, says Leerink
Leerink analyst Danielle Antalffy believes the recent selloff in Johnson & Johnson's shares was overdone and would recommend buying on weakness. The analyst views the company as well-equipped to manage the inevitable Remicade headwind and continues to believe Johnson & Johnson can drive improving top-line growth in 2017. She reiterates an Outperform rating and $140 price target on the shares.
10/19/16
UBSW
10/19/16
NO CHANGE
Target $144
UBSW
Buy
Johnson & Johnson has potential upside from expanding pipeline, says UBS
UBS analyst Matt Miksic noted Johnson & Johnson delivered a solid quarter and said he believes there is upside to his Buy thesis. The analyst cited the company's expanding pipeline, capital allocation strategy, and contracting across its broad portfolio and patient assistance programs is expected to help mitigate pressure from biosimilar competition. Miksic reiterated his Buy rating and raised his price target to $144 from $137 on Johnson & Johnson shares.
11/09/16
RBCM
11/09/16
NO CHANGE
RBCM
Johnson & Johnson should be bought on recent weakness, says RBC Capital
After meeting with J&J's VP, Investor Relations, RBC Capital analyst Glenn Novarro says that the company's Q3 pharma results indicate that the growth of its major drugs can more than offset any declines in Remicade sales next year. The analyst quotes J&J as saying that it has not been using price hikes to increase its sales, and he thinks that the company's diverse business model will allow it to avoid being hurt by any regulatory pressures. He is upbeat on the company's efforts to increase its margins and notes that its medical device results have improved. Novarro keeps a $133 price target and an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

JD

JD.com

$43.08

0.13 (0.30%)

10:10
06/27/17
06/27
10:10
06/27/17
10:10
Options
Closing buyer in JD.com Jan 40 strike puts »

Closing buyer in JD.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPPGY

WPP PLC

$105.93

0.11 (0.10%)

10:07
06/27/17
06/27
10:07
06/27/17
10:07
Periodicals
WPP affected by cyber attack, Reuters reports »

Reuters cites a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNRO

Monro Muffler

$45.95

1.2 (2.68%)

, AMZN

Amazon.com

$993.98

-9.76 (-0.97%)

10:04
06/27/17
06/27
10:04
06/27/17
10:04
Recommendations
Monro Muffler, Amazon.com analyst commentary  »

Stephens sees Monro…

MNRO

Monro Muffler

$45.95

1.2 (2.68%)

AMZN

Amazon.com

$993.98

-9.76 (-0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

10:03
06/27/17
06/27
10:03
06/27/17
10:03
General news
Consumer Confidence data reported »

June Consumer Confidence…

OIH

Oil Services Holders Trust

$24.35

-0.02 (-0.08%)

10:00
06/27/17
06/27
10:00
06/27/17
10:00
Options
VanEck Vectors Oil Services ETF with notable option action »

VanEck Vectors Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:00
06/27/17
06/27
10:00
06/27/17
10:00
General news
U.S. Consumer Confidence Preview: »

U.S. Consumer Confidence…

COST

Costco

$160.20

3.07 (1.95%)

09:59
06/27/17
06/27
09:59
06/27/17
09:59
Conference/Events
Costco management to meet with Deutsche Bank »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 23

    Aug

AA

Alcoa

$31.97

0.79 (2.53%)

09:57
06/27/17
06/27
09:57
06/27/17
09:57
Recommendations
Alcoa analyst commentary  »

Alcoa price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

K

Kellogg

$70.16

-0.83 (-1.17%)

09:55
06/27/17
06/27
09:55
06/27/17
09:55
Options
Kellogg put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCI

Crown Castle

$103.16

3.41 (3.42%)

, DRI

Darden

$92.62

2.54 (2.82%)

09:55
06/27/17
06/27
09:55
06/27/17
09:55
Options
Early notable gainers among liquid option names on June 27th »

Notable gainers among…

CCI

Crown Castle

$103.16

3.41 (3.42%)

DRI

Darden

$92.62

2.54 (2.82%)

KSS

Kohl's

$38.27

0.75 (2.00%)

M

Macy's

$22.76

0.2944 (1.31%)

AMT

American Tower

$135.11

2.65 (2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 18

    Jul

  • 19

    Jul

  • 21

    Sep

NDAQ

Nasdaq

$70.30

0.44 (0.63%)

, CBOE

CBOE Holdings

$89.62

0.85 (0.96%)

09:55
06/27/17
06/27
09:55
06/27/17
09:55
Conference/Events
House Financial Services Committee to hold a hearing Nasdaq CBOE Holdings Charles Schwab »

The Capital Markets,…

NDAQ

Nasdaq

$70.30

0.44 (0.63%)

CBOE

CBOE Holdings

$89.62

0.85 (0.96%)

SCHW

Charles Schwab

$42.35

0.5 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 26

    Jul

CME

CME Group

$123.65

-0.47 (-0.38%)

, CS

Credit Suisse

$14.23

0.26 (1.86%)

09:55
06/27/17
06/27
09:55
06/27/17
09:55
Conference/Events
House Agriculture Committee to hold a hearing »

The Committee holds a…

CME

CME Group

$123.65

-0.47 (-0.38%)

CS

Credit Suisse

$14.23

0.26 (1.86%)

ICE

IntercontinentalExchange

$64.59

0.24 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 01

    Aug

KW

Kennedy Wilson

09:54
06/27/17
06/27
09:54
06/27/17
09:54
Conference/Events
Kennedy Wilson management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

IRBT

iRobot

$100.98

-0.22 (-0.22%)

09:52
06/27/17
06/27
09:52
06/27/17
09:52
Periodicals
iRobot mentioned cautiously by Spruce Point Capital 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFO

IHS Markit

$46.40

-0.15 (-0.32%)

09:51
06/27/17
06/27
09:51
06/27/17
09:51
Conference/Events
IHS Markit management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

ALNY

Alnylam

$82.92

-2.29 (-2.69%)

09:50
06/27/17
06/27
09:50
06/27/17
09:50
Conference/Events
Alnylam participates in a conference call with Piper Jaffray »

Piper Jaffray Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

APDN

Applied DNA Sciences

$1.40

0.31 (28.44%)

09:49
06/27/17
06/27
09:49
06/27/17
09:49
Hot Stocks
Applied DNA Sciences signs new licensing agreement with Himatsingka America »

Applied DNA Sciences is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPC

Pilgrim's Pride

$22.40

-0.44 (-1.93%)

09:45
06/27/17
06/27
09:45
06/27/17
09:45
Periodicals
Humane Society issues report making allegations on Pilgrim's Pride supply chain 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
06/27/17
06/27
09:45
06/27/17
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

June Richmond Fed…

09:45
06/27/17
06/27
09:45
06/27/17
09:45
General news
Consumer Confidence to be reported at 10:00 »

June Consumer Confidence…

PFE

Pfizer

09:42
06/27/17
06/27
09:42
06/27/17
09:42
Hot Stocks
Pfizer expects to hire additional 80 employees for R&D facility in coming years »

Pfizer (PFE) broke ground…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

  • 02

    Aug

  • 27

    Aug

KSS

Kohl's

09:40
06/27/17
06/27
09:40
06/27/17
09:40
Options
Kohls calls lead puts 50:1 in early chatter-driven flow »

Kohls calls lead puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIAB

Viacom

$35.09

0.98 (2.87%)

, OIH

Oil Services Holders Trust

09:40
06/27/17
06/27
09:40
06/27/17
09:40
Options
Unusually active option classes on open June 27th »

Unusual total active…

VIAB

Viacom

$35.09

0.98 (2.87%)

OIH

Oil Services Holders Trust

MDLZ

Mondelez

CLF

Cliffs Natural

RAD

Rite Aid

WDC

Western Digital

$92.66

-0.68 (-0.73%)

S

Sprint

KO

Coca-Cola

GM

General Motors

SLV

iShares Silver Trust

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Jul

  • 03

    Aug

  • 16

    Nov

NWS

News Corp

$14.10

0.05 (0.36%)

, NWSA

News Corp.

$13.66

0.07 (0.52%)

09:39
06/27/17
06/27
09:39
06/27/17
09:39
Hot Stocks
News Corp 'applauds' European Commission's decision to fine Google »

The following statement…

NWS

News Corp

$14.10

0.05 (0.36%)

NWSA

News Corp.

$13.66

0.07 (0.52%)

GOOG

Alphabet

$952.27

-13.32 (-1.38%)

GOOGL

Alphabet Class A

$972.09

-14 (-1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

BAP

Credicorp

09:35
06/27/17
06/27
09:35
06/27/17
09:35
Downgrade
Credicorp rating change  »

Credicorp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.